Plasma Medical Devices

https://korean-electronics.com//inquiry

[INQ. NO. 2610E05] FEAGLE Co., Ltd., a company specializing in plasma medical devices, has been focusing its R&D efforts on the field of plasma medicine, an area gaining attention as next-generation medical technology.
Over the past 12 years of plasma technology research, FEAGLE has expanded its product lineup to include everything from medical devices for hospitals and clinics to equipment for aesthetic clinics and beauty devices for home care.
Its core technology is the proprietary Nozone Cold Plasma (NCP). According to FEAGLE, NCP is designed to maintain the characteristics of cold plasma while minimizing ozone generation during the plasma-production process — reducing levels to less than one-tenth of the standards set by the FDA and the Ministry of Food and Drug Safety.

FEAGLE is expanding the scope of its technology beyond professional equipment to include homecare products for consumers. Its flagship product, PLUNA, is a personal plasma beauty device based on NCP technology; it brings plasma technology — previously reserved for professional facilities — into the realm of everyday skincare.
PLUNA features a portable, handheld design and is engineered to enable plasma-based homecare, while minimizing direct physical irritation to the skin. The company’s strategy is to target both professional and consumer markets by applying the same core plasma technology to products for clinics and home-use alike.

Alongside its technological development, FEAGLE is accelerating its expansion into overseas markets. It is currently selling products or conducting local medical device certification and pre-marketing activities in regions including Hong Kong, the USA, Mexico, Indonesia, Malaysia, Vietnam, and Russia. In particular, viewing the United States as a key market, FEAGLE has spent approximately a year conducting local testing and market validation, and is now moving to significantly expand sales based on these results. FEAGLE is also pursuing medical-device certification in countries such as Mexico, Russia, and Thailand, with plans to expand local distribution and marketing once certification is secured.
In the long term, FEAGLE plans to develop its NCP technology into a platform capable of overcoming the limitations — such as physical irritation and invasiveness — associated with conventional medical and beauty devices. With the demand for non-invasive treatments and care steadily rising, the company aims to expand its plasma technology into a diverse range of medical and aesthetic products, thereby tapping into new application markets.




korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Healthcare Medical Devices

https://korean-electronics.com//inquiry

[INQ. NO. 2610E04] 3H Co., Ltd. recently unveiled its healthcare medical devices and various acupressure bed products developed using spinal acupoint acupressure and thermal technologies.
Leveraging its proprietary technology and manufacturing capabilities, the company has built a product lineup centered on acupressure beds. Recently, it has expanded its business scope into the health and beauty sectors, strengthening its product portfolio to cater to diverse consumer lifestyles.
Its flagship acupressure bed is a healthcare medical device that combines acupressure, moxibustion, and massage functions, delivering acupoint acupressure and thermal stimulation along the spine. Designed for use while lying down, the bed stimulates key areas of the body and applies heat to help alleviate muscle pain and support daily health management.

3H is also focusing on product development that considers not only functionality but also home integration and design. Moving beyond the traditional image of medical devices, the company incorporates forms and materials that blend naturally into living spaces — while enhancing both usability and aesthetics to make health management more convenient for consumers.
Accordingly, 3H is expanding its business footprint in overseas markets. Currently, the company exports products to key nations such as the USA, China, Taiwan, Vietnam, Indonesia, Canada, and Australia. It also consistently participates in global exhibitions, including CES (Las Vegas, USA), Medi-Pharm (Hanoi, Vietnam), the K-Product Premium Consumer Goods Fair (France), medical device exhibitions in Guangzhou and Shanghai (China), and the Jakarta International Hospital Expo (Indonesia).

3H is securing country-specific product certifications and advancing related procedures in major markets — including the United States, China, Japan, Taiwan, Southeast Asia, Europe, Canada, and Australia — while strengthening its distribution infrastructure through overseas subsidiaries and local distributor networks. It also plans to enhance product technology and credibility by collaborating with overseas medical institutions and conducting clinical research.
In particular, given the importance of firsthand product experience for its acupressure beds, 3H is focusing on conveying product functions and user experiences through local exhibitions and experiential marketing activities.


korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Seated Healthcare Device

https://korean-electronics.com//inquiry

[INQ. NO. 2610E03] Established in 2019, Samhwa Medical develops and manufactures healthcare products designed for convenient daily use, primarily under its ‘SOMOKO’ brand.
Samhwa Medical has been expanding its home-care product lineup through presenting various products such as ‘SERAFION’ and ‘Body Love.’ The SERAFION SM-2300 is a seated healthcare device designed for modular use. It combines the following functions: thermal, vibration, magnetic field, and LED light care — allowing users to reconfigure the device to suit different body parts, such as the waist, abdomen, and limbs.
The device features a total of 440 dual-wavelength LEDs, comprising 220 near-infrared LEDs and 220 red-light LEDs that operate in conjunction with the thermal function. The heat level is adjustable across five settings ranging from 35°C to 55°C. Additionally, the device integrates three vibration modes and magnetic field therapy, providing comprehensive home-care capabilities in a single unit.

Notably, it features a three-way structure that allows the top and bottom panels to be used in flat, folded, or separated configurations. Users can unfold the device to treat areas like the feet or legs, fold it to wrap around specific body parts, or detach the panels to apply them to different areas simultaneously.

The top panel utilizes a wireless design powered by two 3,000mAh batteries for enhanced portability and ease of use on various body parts, while the bottom panel operates on a DC 15V/90W power supply. The included adapter supports a voltage range of 100–240V, making it suitable for use in overseas markets.
Samhwa Medical has already obtained KC certification for electrical safety and electromagnetic wave for its SERAFION SM-2300, and Samhwa Medical is currently pursuing CE, FCC, and PSE certifications to facilitate expansion into European, U.S., and Japanese markets. The company plans to target various overseas markets — including Japan, Taiwan, and European nations like Germany and France — and is preparing to identify local distribution partners.
Samhwa Medical focuses its product development on enabling consumers who find it difficult to frequently visit hospitals or specialized care facilities to manage their health conveniently at home. Its primary target demographics include office workers who sit for long periods, individuals experiencing physical fatigue from housework or childcare, and customers seeking homecare products for their parents’ health management.




korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Medical Device for Skin Treatment

https://korean-electronics.com//inquiry

[INQ. NO. 2610E02] JSDR has been focused on addressing skin problems that are difficult to treat with conventional aesthetic procedures — such as deep wrinkles and depressed scars — by developing the SDR treatment method and its dedicated medical equipment. Rather than simply delivering energy to the skin, the device focuses on enabling medical professionals to precisely control the process of micro-injecting necessary substances into specific locations.
JUVGEN, the company’s flagship product, is designed for SDR procedures that involve the micro-injection of CO₂ and hyaluronic acid (HA) into the dermal layer of the skin. JSDR explains that the core principle of SDR is inducing skin tissue regeneration and collagen formation through the precise delivery of these two substances to the treatment area.

A key feature of JUVGEN is its precision in micro-injection. The device allows for injection volume control in increments as small as 0.001cc, enabling medical professionals to fine-tune treatment parameters according to the specific area and the patient’s skin condition. It is designed to ensure consistent management of injection volume and placement, which is crucial for aesthetic procedures requiring precision over relatively small areas, such as deep wrinkles and sunk scars.
Additionally, by integrating the use of both CO₂ and HA into a single system, the device minimizes potential inconsistencies associated with repetitive manual steps and streamlines the treatment workflow. The company developed its product by combining the precision control capabilities of the equipment with a procedure that previously relied solely on the practitioner’s experience, thereby enhancing the reproducibility and ease of use of SDR treatments.

The starting point for product development was the treatment method itself rather than the equipment alone. After researching Autologous Dermal Regeneration (SDR) — a technique applicable to deep wrinkles and depressed scars — JSDR developed JUVGEN, a dedicated device designed to enable medical professionals to perform the procedure with greater accuracy and consistency.
Consequently, JUVGEN was designed as a comprehensive system that integrates the treatment protocol with the hardware, rather than serving merely as an injection device. Medical professionals can configure necessary treatment parameters and monitor progress via the touchscreen on the front of the unit, while an intuitive user interface ensures quick access to essential functions during the procedure.
JUVGEN’s handpiece incorporates a dual-chamber syringe system that combines two injection pathways into a single structure. This design enables the precise delivery of CO₂ and HA during the procedure and minimizes the need for medical professionals to repeatedly switch instruments. In particular, the section of the handpiece that makes direct contact with the skin is designed to allow for stable operation, while enabling the practitioner to verify the injection site. A key feature is the integration of the settings configured on the main unit with the handpiece’s precision injection mechanism, allowing the entire procedure to be managed within a unified system.

Efforts are being stepped up to promote JUVGEN and SDR in overseas markets. To this end, JSDR is collaborating with local medical device distributors and aesthetic medicine professionals, primarily in Asia, and is gradually broadening its export reach by securing necessary regulatory approvals and distribution partners in each country.
Furthermore, by participating in major global aesthetic medicine conferences and exhibitions — such as IMCAS and AMWC— the company introduces international medical professionals to the SDR procedure and JUVGEN’s precision injection technology. The strategy goes beyond mere equipment exports: it aims to introduce the new procedural method itself to overseas markets by simultaneously establishing training programs for medical professionals and building clinical networks.


korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Korea Continues Remarkable Export Drives

https://korean-electronics.com//inquiry

Ceaselessly Presenting New Competitive Items
South Korea recorded its highest-ever monthly exports — surpassing the $120 billion mark — last month, thereby exceeding $800 billion in annual exports for the first time in history.
Semiconductor exports in September hit $60.3 billion, a massive 262.8% increase year-on-year, marking the first time the sector has crossed the $60 billion threshold. This surge followed three consecutive months of exports exceeding $40 billion.
The semiconductor sector maintained strong momentum, fueled by sustained demand for memory chips, increased export volumes, and rising fixed prices. Prices steadily climbed; for instance, the price of DDR5 16Gb chips rose from $37.50 in May to $48.00 last month, while NAND 128Gb chips increased from $26.50 to $30.60 over the same period.

Other IT products also showed strong performance. Computer exports surged by 435.3%, driven by rising demand for enterprise-grade solid-state drives (SSDs) — a trend fueled by the proliferation of agentic AI and expanded global investment in AI infrastructure. Exports reached $7 billion, marking an all-time monthly high.
Exports of wireless communication devices climbed by 23.4% to $2.14 billion — extending a streak of growth to 11 consecutive months — driven by strong sales of premium models like the Galaxy Z8 series and S26 Ultra, as well as increased exports of iPhone components.

While accomplishing such remarkable export performance, Korean export companies are ceaselessly releasing new competitive products and knocking on the doors of global markets. Creative efforts are ceaselessly being made toward accomplishing their higher export performance goals for this year.
Samhwa Medical has been expanding its homecare product lineup through presenting various products such as SERAFION and Body Love. The SERAFION SM-2300 is a seated healthcare device designed for modular use. It combines the following functions: thermal, vibration, magnetic field, and LED light care — allowing users to reconfigure the device to suit different body parts, such as the waist, abdomen, and limbs.
FEAGLE, a company specializing in plasma medical devices, is expanding the scope of its technology beyond professional equipment to include homecare products for consumers. Its flagship product, PLUNA, is a personal plasma beauty device based on NCP technology; it brings plasma technology — previously reserved for professional facilities — into the realm of everyday skincare. PLUNA features a portable, handheld design and is engineered to enable plasma-based homecare while minimizing direct physical irritation to the skin.




korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Integrated Healthcare Solutions

https://korean-electronics.com//inquiry

Combining In Vitro Diagnostic (IVD) Devices with on-device AI technology
[INQ. NO. 2609E05] ZIODIA Co., Ltd., a company specializing in IVD medical devices and AI healthcare, will participate in KIMES BUSAN 2026 to be held at BEXCO in Busan from October 23 to 25, to introduce an integrated healthcare solution combining IVD devices with on-device AI technology.
With the vision of ‘promoting human health through early disease diagnosis,’ ZIODIA is developing IVD medical devices and digital healthcare platforms. The company aims to build an environment where primary care institutions and individual users can more conveniently check their health status by miniaturizing and automating complex diagnostic systems currently centered on large medical institutions.
ZIODIA’s core competitive edge lies in Bio-MEMS, Lab-on-a-chip, and microfluidic control technologies. It is independently developing diagnostic devices and dedicated cartridges capable of analyzing disease-related biomarkers from minute sample volumes and quantitatively interpreting fluorescence signals.
In particular, the company is highlighting its key technologies as a three-column diagnostic platform capable of analyzing various types of biomarkers in parallel, and on-device AI technology that processes data directly on the device. The company explains that by performing analysis internally without relying on external cloud servers, it can provide rapid results even in environments with limited network connectivity, and reduce security risks by minimizing the external transmission of sensitive medical and biological data.
Through this exhibition, ZIODIA plans to showcase its major product lines, consisting of MadaCheck, ZioCheck, ZioCheck Multi, and ZioSkin.

In-Vitro Diagnostic Platform
MadaCheck is an in vitro diagnostic (IVD) platform developed with the intuitiveness and convenience required for point-of-care diagnosis in mind. The user interface is designed to allow field users to operate the device without complex training, and it is designed for use in medical environments both domestically and internationally through multilingual support, including Korean and English.
ZIODIA is also expanding MadaCheck into a platform for oral health self-diagnosis and preventive care. The diagnostic kit and software have been integrated to allow users to conveniently test for harmful bacteria in their oral cavities, check results via a mobile application, and manage their health trends.
Recognized for these technological capabilities and market potential, ZIODIA was awarded the Grand Prize in the healthcare sector for oral health self-diagnostics at the 11th Korea Business Awards in 2025.

Single-marker Fluorescent Immunoassay Analyzer
ZioCheck is a single-marker fluorescent immunoassay analyzer that quantitatively analyzes specific disease markers and biomarkers. It was developed to secure the necessary data for analysis even from low-concentration samples by applying an optical sensor that detects minute fluorescence signals and a signal-processing algorithm. The focus was on enhancing the objectivity and consistency of results by reducing noise generated during the analysis process and extracting the necessary fluorescence signals. It can be utilized by medical institutions and testing laboratories for the quantitative measurement of specific biomarkers.

Multi-marker Analysis Platform
ZioCheck Multi is a multi-marker analysis platform developed to allow the simultaneous analysis of various types of markers with a single sample collection. It processes multiple diagnostic reagents in parallel through a three-row cartridge structure and instrument architecture designed in-house by ZIODIA.
It is characterized by its ability to reduce overall testing time and increase throughput compared to methods that examine individual items sequentially. The goal is to utilize it extensively in testing environments where infectious diseases or complex symptoms need to be identified by integrating multiple analysis results.
Beyond the realm of in-vitro diagnostics, ZIODIA is also expanding its AI-based personalized healthcare business. ZioSkin is a diagnostic assistance solution that analyzes scalp and skin images and quantifies their condition based on deep learning technology.

By applying edge-computing-based on-device AI utilizing high-performance Neural Processing Units (NPUs), it analyzes high-capacity images in real-time within the device. It provides objective data on indicators related to scalp and skin condition, balance, and severity, supporting medical professionals and administrators in consultations and the establishment of management programs. Since it can analyze images directly on the device without transmitting them to external servers, it has secured a competitive edge in terms of personal information protection and data-security.

ZIODIA plans to expand its scope of application to include kiosk-type products for professional medical institutions and aesthetic clinics, as well as home-device-type products for individuals and small businesses.
Based on its domestic technological development achievements, ZIODIA is establishing a foundation for overseas expansion targeting the Chinese, Southeast Asian, and North American markets. It has signed a business agreement with the Vietnam University of Agriculture and Forestry for clinical trials and joint research, and is pursuing the development of diagnostic devices suitable for local environments and the securing of clinical data. It has also signed a dealership agreement and a business agreement with Prenovo, a Chinese company specializing in diagnostic devices. The plan is to establish a two-way cooperation model that involves distributing Prenovo’s products domestically while simultaneously supplying the company’s proprietary diagnostic solutions to the Chinese market by leveraging Prenovo’s local sales network and experience in medical device licensing.

ZIODIA is expanding its business beyond human diagnostics into the field of in vitro diagnostics for animals. Based on cooperation with local institutions in Vietnam, it is preparing for clinical trials and the commercialization of diagnostic solutions capable of rapidly testing livestock infectious diseases, such as foot-and-mouth disease, on-site. Furthermore, ZIODIA plans to pursue a strategy to supply on-site diagnostic platforms to countries lacking medical and disease-control infrastructure in conjunction with the KOICA CTS project.
To enter the North American market, ZIODIA was selected for a global expansion support program organized by the Gangwon Creative Economy Innovation Center and has designated Canada as its primary target market. The company plans to establish a foundation for entering the North American market by formulating local medical device licensing strategies and identifying distribution and business partners.
“Through this exhibition, we will introduce our technology roadmap, which spans from single biomarker analysis to multi-testing and image-based on-device AI. We aim to grow into a global enterprise encompassing in vitro diagnostics and AI healthcare by expanding cooperation with medical institutions, testing laboratories, healthcare companies, and overseas distribution partners,” commented a spokesperson for the company.

korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Cloud-based Medical Platform

https://korean-electronics.com//inquiry

[INQ. NO. 2609E04] Medical IT company TNH Co., Ltd. will participate in KIMES BUSAN 2026, to be held at BEXCO in Busan from October 23 to 25, to introduce solutions that support the digital transformation of medical institutions, including cloud-based EMR and CRM systems and collaboration platforms dedicated to hospitals and clinics.
TNH is a company that has developed cloud medical platforms supporting overall hospital operations. It focuses on efficiently connecting the diverse tasks occurring within medical institutions — ranging from medical record management to appointments, consultations, billing, insurance claims, customer management, and internal communication — all within a single environment.

Currently, an average of over 15,000 medical professionals and hospital staff daily at approximately 3,000 hospitals and clinics nationwide in Korea use TNH’s solutions. While maintaining continuous revenue growth over the past four years, the company is integrating AI technology into its existing EMR and CRM services and expanding its service scope to include internal hospital collaboration.
At this exhibition, TNH introduces a cloud-based medical platform that connects the entire spectrum of hospital operations, centering on its flagship solutions — ‘VegasCRM,’ and ‘HanChartCloud’— an EMR tailored for Korean Oriental medicine clinics — and ‘Starfruit,’ a newly introduced collaboration platform designed exclusively for hospitals and clinics.
VegasCRM is a cloud-based EMR and CRM solution capable of integrated management of key tasks essential for hospital operations — ranging from appointments and consultations to medical treatment, billing, insurance claims, and customer management. It offers features such as an integrated appointment system that connects multiple booking channels; automated customer guidance based on treatment history; and management of packages, points, and prepayments. Support for consultation tasks utilizing AI technology has also been enhanced. It automatically summarizes phone consultation content and analyzes consultation data to identify risks of customer churn or potential complaints.
The company explains that this allows for the reduction of repetitive tasks during consultations, and enables more consistent management of consultation processes that can vary depending on the staff member. Key clients are hospitals and clinics in the fields of dermatology, plastic surgery, and aesthetic medicine, where appointments, consultations, and customer management are of high importance. TNH highlights its competitive edge as a structure in which sales and contact organizations directly collect requirements from the field, share them with planning, design, and development teams, and reflect them in the product.

HanChartCloud is a cloud-based EMR solution developed specifically for the work environment of Korean Oriental medicine clinics that offer both therapeutic and cosmetic treatments. It supports medical record management, automobile insurance-related tasks, image storage, and patient management, all within a single platform.
It is designed to efficiently manage the workflow extending from patient registration to treatment, payment, and administrative tasks by providing integration with Naver and Kakao reservations, as well as indemnity insurance claims and reception functions utilizing the ‘HiOSK’ kiosk.

TNH expanded its service scope to include internal communication with the launch of ‘Starfruit,’ a collaboration platform designed exclusively for hospitals and clinics, in the second half of 2026. Starfruit integrates with EMRs in real-time, enabling employees working in different locations — such as treatment rooms, consultation rooms, and reception desks — to quickly share work information and requests.
Starfruit allows users to view patient charts directly from the messenger screen and offers features to reduce patient waiting inconvenience by providing notifications regarding treatment-room waiting times. It enables integrated management of various social media consultation channels and supports communication with foreign patients by utilizing AI translation functions. Another key feature is its support for both Android and iOS mobile environments, allowing hospital staff to check tasks and collaborate in real-time regardless of location.
Through this, TNH expects the EMR to evolve beyond a system for only managing medical records into a platform that connects the actual workflow and communication of hospital staff.
At KIMES BUSAN 2026, TNH plans to operate an exhibition booth to allow visitors to experience the three solutions firsthand, and introduce how AI and cloud technologies are applied to actual hospital operations. In particular, it will propose an integrated operational environment that encompasses treatment, appointments, consultations, customer management, and internal collaboration to officials from medical institutions in the Yeongnam region.
The CEO of TNH explained, “Our goal is to help hospitals operate more efficiently, provide excellent patient experiences, and achieve sustainable growth through technology,” adding “We will continue to actively utilize AI technology to continuously develop and enhance services that meet the demands of the medical field.”


korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Musculoskeletal X-ray Image-Analysis Solution

https://korean-electronics.com//inquiry

[INQ. NO. 2609E03] WALK101 Co., Ltd., an AI-based musculoskeletal medical image analysis company, aims to introduce its musculoskeletal X-ray image-analysis solution, GMSM, at KIMES BUSAN 2026.
WALK101 is developing AI medical software that automatically identifies key anatomical points in musculoskeletal X-ray images and measures, and analyzes clinically necessary indicators. The company was founded by CEO Dong-sik Chae, an orthopedic surgeon, with the goal of resolving the inefficiencies of repetitive measurement and interpretation processes experienced in actual clinical practice, and contributing to the early detection and prevention of musculoskeletal diseases.

The flagship solution, GMSM, supports X-ray images of various musculoskeletal areas — including the spine, hips, knees, ankles, feet, wrists, elbows, and shoulders — within a single AI analysis system. It automatically identifies key anatomical landmarks in images, measures clinical indicators, and analyzes abnormal findings to provide structured information that medical professionals can utilize for diagnosis and interpretation.
A key feature is its design that integrates with hospital PACS systems, allowing for seamless integration into the workflow of actual medical practices. The system operates by automatically receiving X-ray images from PACS, performing AI analysis, and then transmitting the results back to the PACS. The company explains that this reduces repetitive manual measurement tasks performed by medical staff and enables the provision of quantitative and consistent analytical information.
WALK101 has currently obtained a total of 19 digital medical-device approvals in Korea related to musculoskeletal X-ray AI. These include the Class II medical device ScanoX, as well as solutions targeting various anatomical regions such as FOOTAIX, Knee_AP_AIX, Hip_AP_AIX, and Shoulder_AIX.
WALK101 has also established quality-control and information-security systems. It has secured certifications including KGMP and ISO 13485, as well as ISO 27001 and ISO 27701 for information security and personal-data protection. It is enhancing the reliability and clinical applicability of its products through continuous research and clinical validation with domestic university hospitals and medical institutions.
WALK101’s differentiation from its competitors rests in supporting a diverse range of musculoskeletal domains within a single platform, going beyond AI analysis limited to specific body parts. Its GMSM was developed to be utilized within actual hospital imaging diagnostic workflows, rather than as a separate, independent AI program, by providing not only automatic measurement and abnormality analysis but also PACS integration.
Key customers are hospitals and medical institutions that perform musculoskeletal X-ray examinations. Targeting medical professionals in departments such as radiology and orthopedics who interpret X-ray images or perform repetitive clinical measurements, WALK101 is expanding its market by focusing on medical institutions seeking to improve the efficiency of image analysis and the consistency of measurement results.

At KIMES BUSAN 2026, the key features and practical applications of GMSM will be introduced to domestic and international medical professionals, including those at medical institutions in the Busan and Yeongnam regions. The company plans to expand its networks covering hospitals, medical institutions, and medical device distribution and business partners, while identifying the needs of actual clinical practice to reflect them in future product advancements. Meanwhile, it is also accelerating its entry into overseas markets.

Currently, WALK101 is pursuing business primarily in the United States and Vietnam, having established a local business base and representative system in the USA. In Southeast Asia, including Vietnam, it is collaborating with local medical institutions and partners to proceed with clinical validation, local application, and commercialization in stages.
Moving forward, WALK101 plans to pursue seeking local medical device regulatory approvals, secure clinical data, and integrate with hospital PACS environments in major overseas markets, including the United States and Vietnam, while also identifying reliable distribution and business partners. At the same time, the company intends to strengthen its business foundation in the global musculoskeletal medical AI market by continuously expanding the applicable anatomical regions and analysis capabilities of GMSM.
A spokesperson for the company commented, “Our GMSM is a solution designed to improve clinical efficiency and the consistency of analysis results by automating the repetitive tasks of musculoskeletal X-ray measurement and analysis performed by medical staff using AI. We will expand cooperation with domestic and international medical institutions and partners through KIMES BUSAN 2026 and develop it into a musculoskeletal medical AI platform that is practically utilized in clinical settings.”

korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Total Aesthetic Solution Combining Cosmetics and Beauty Devices

https://korean-electronics.com//inquiry

[INQ. NO. 2609E02] MIZCOSMETIC has completed its preparations for KIMES BUSAN to showcase a total beauty solution encompassing face & body care devices and professional aesthetic cosmetics.
Established in 2006, MIZCOSMETIC is a professional beauty company that develops and supplies cosmetics and skin and body care devices used in skincare clinics and specialized aesthetic institutions.

It markets the professional aesthetic cosmetic brands HUTEMCELL and TBM, offering a diverse range of products including ampoules, creams, and face masks.
In addition, MIZCOSMETIC has developed aesthetic devices incorporating various technologies such as radio frequency (RF), ultrasound, and iontophoresis, providing support ranging from product-supply to device-usage training, demonstrations, management program proposals, and consulting. The company explains that it goes beyond simply supplying cosmetics and beauty devices individually, by instead proposing them as a comprehensive management system that can be utilized together in actual skincare settings.
Domestically, MIZCOSMETIC has established a specialized distribution network centered on skin care clinics and professional aesthetic institutions. It is enhancing on-site usability by conducting training and demonstrations to ensure that the characteristics of its products and devices can be effectively applied to management programs.

MIZCOSMETIC is also continuously expanding its presence in overseas markets. Currently, it exports aesthetic cosmetics and beauty devices to the UAE, the United States, Singapore, Japan, Uzbekistan, Vietnam, and Hong Kong, and is identifying distribution partners in each country through overseas exhibitions and consultations with local buyers. Through this exhibition, MIZCOSMETIC plans to introduce its key products to domestic and international buyers and industry professionals in the beauty and aesthetic sectors, as well as to discover new distribution partners. The company intends to identify market demands and reactions through product demonstrations and face-to-face consultations, and incorporate them into future product development and strategies for expanding into overseas markets.

The key equipment to be introduced at this exhibition includes NUBELLIS, EINXEL, and THERMATRIX.
NUBELLIS is a face- and body-care device utilizing microwave technology. Designed for face line and body contouring based on energy delivery and cooling functions, it allows for customized program configurations tailored to specific treatment areas and purposes.
EINXEL is a needle RF device that combines micro-needles with high-frequency energy. It allows for precise adjustment of energy and application depth according to skin condition and treatment objectives, making it suitable for intensive care programs focused on skin texture and elasticity.

THERMATRIX is a face lifting and firming device that utilizes high-frequency energy. It enables professional facial care tailored to individual skin conditions and features an unlimited cartridge system that reduces the burden of consumables and enhances the economic efficiency of equipment operation.

The professional aesthetic cosmetics brand, HUTEMCELL, is also being introduced. It is a professional cosmetic brand utilizing human adipose-derived stem cell culture fluid and PDRN as key ingredients. It boasts a product lineup ranging from basic skincare — including toners, ampoules, creams, and mask packs — to professional skincare programs. Representative products include Powder Cream, which transforms from a powder into an essence cream texture, and Exoball Ampoule, having a dual structure that separates the oil layer from the moisture ampoule layer.
MIZCOSMETIC explained that it has enhanced the professionalism and practical applicability of its products based on differentiated formulations and ingredients. The company’s greatest competitive advantage lies in its ability to propose professional cosmetics and beauty devices as a single management system. Based on 20 years of accumulated field experience in aesthetics, the company curates cosmetics, devices, and programs tailored to specific skin concerns and management goals — in order to provide customers with systematic management solutions and aesthetic operators with operational plans that consider both usability and cost-effectiveness.
“Our differentiation lies in reflecting the demands of the aesthetic field in our products and technology, and providing total solutions that allow for the combined use of cosmetics and beauty devices. We will directly demonstrate our products and meet with domestic and international buyers to expand opportunities for long-term distribution cooperation,” explained a spokesperson for the company.
Moving forward, MIZCOSMETIC plans to review country-specific certifications and distribution environments with the goal of entering the European market. The plan is to expand export business by strengthening product development and marketing tailored to local regulations and consumer demand, and by identifying specialized partners capable of distributing both cosmetics and beauty devices.


korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

KIMES BUSAN 2026 to Showcase Diverse Advanced Medical Solutions

https://korean-electronics.com//inquiry

KIMES BUSAN 2026 — (also known as ‘The 14th KIMES BUSAN International Medical & Hospital Equipment Show’), which aims to revitalize the medical and hospital industries in the Yeongnam region and showcase evolving medical technologies in line with global trends — will be held at BEXCO in Busan from October 23 to 25.
At KIMES BUSAN 2026, a wide range of advanced medical solutions will be introduced in line with global trends — such as platforms for the efficient management and sharing of medical information, health data collection via IoT sensors and apps, online consultations with medical staff, and medical technologies utilizing healthcare algorithms.

As an international gathering of medical experts, KIMES BUSAN 2026 will host medical professional conferences, academic conferences, and various medical industry seminars, providing an optimal platform for interacting with representatives of hospitals and clinics, and with other medical professionals.

Among the exhibitors, Korea’s TNH is scheduled to introduce a cloud-based medical platform that connects the entire spectrum of hospital operations, focusing on its flagship solutions VegasCRM, and HanChartCloud — Electronic Medical Records (EMRs) developed for Korean Oriental medicine clinics — and ‘Starfruit,’ a newly introduced collaboration platform exclusively for hospitals and clinics.
ZIODIA, a company specializing in In Vitro Diagnostic (IVD) medical devices and AI healthcare, plans to showcase its major product lines, consisting of MadaCheck, ZioCheck, ZioCheck Multi, and ZioSkin.

KIMES Busan 2026, the largest medical device exhibition in the Yeongnam region, establishes various networks including B2B, B2C, and C2C, and provides opportunities for communication between exhibitors and customers. In particular, since 2020, it has been held in conjunction with the regional medical decentralization forums and K-Medi Fair, thus contributing to the improvement of the regional medical environment and the narrowing of medical disparities between regions.

korean-electronics.com | Blog Magazine of korean electronics, brands and Goods